v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 3,478 $ 2,320 $ 5,579 $ 4,647
General and administrative 1,907 1,981 3,831 3,540
Total operating expenses 5,385 4,301 9,410 8,187
Loss from operations (5,385) (4,301) (9,410) (8,187)
Other income (expense)        
(Loss) gain from change in fair value of warrant liabilities (4) 160 113 247
Interest income, net 73 146 158 274
Total other income 69 306 271 521
Loss before income taxes (5,316) (3,995) (9,139) (7,666)
Provision for income taxes 0 0 0 0
Net loss $ (5,316) $ (3,995) $ (9,139) $ (7,666)
Loss per share:        
Loss per share of common stock, basic (in dollars per share) $ (0.9) $ (2.87) $ (1.69) $ (6.59)
Loss per share of common stock, diluted (in dollars per share) $ (0.9) $ (2.87) $ (1.69) $ (6.59)
Weighted average shares of common stock outstanding:        
Weighted average shares of common stock, basic (in shares) 5,931,875 1,389,753 5,398,683 1,162,692
Weighted average shares of common stock, diluted (in shares) 5,931,875 1,389,753 5,398,683 1,162,692